Håkan Englund Overview

  • Investor Type
  • Angel

  • Investments
  • 1

  • Exits
  • 1

Exits

Håkan Englund General Information

Description

Mr. Håkan Englund is the Board Member at Immuneed. He served as Board Member at Sensidose. He earlier served as Executive Vice President at Phadia and had prior to that several leading positions within Pharmacia Biotech. He is also an Angel Investor. He is Board member of several medtech/life science companies. He is presently on the board of Arocell (publ), and Olink Bioscience.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • Kungsgatan 70 D
  • 752 41 Uppsala
  • Sweden

Håkan Englund Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Glycobond 08-Apr-2015 Discovery Tools (Healthcare) Bankruptcy: Liquidation

Håkan Englund Exits (1)

Company Name Exit Date Exit Type Exit Size
Glycobond 02-Sep-2024

Håkan Englund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Håkan Englund FAQs

  • Who is Håkan Englund?

    Håkan Englund is an angel Investor who has made 1 investment.

  • What kind of investor is Håkan Englund?

    Håkan Englund is an angel investor.

  • What does Håkan Englund do?

    As an angel investor, Håkan Englund invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Håkan Englund hold?

    Håkan Englund holds a board seat in Immuneed.

  • What has Håkan Englund invested in?

    Håkan Englund has invested in Glycobond within the Discovery Tools (Healthcare) industry.

  • What has Håkan Englund invested in recently?

    Håkan Englund's latest investment was on 08-Apr-2015 in Glycobond, a company within the Discovery Tools (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »